GlassScriptPhysician profile
Andrew S Mathis
NPI 1801265004
$1,225.34
in general payments reported to CMS, 2019-2025
21 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $63.46 · 2023: $194 · 2024: $233 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $351.72 | 2024-2025 | Ozempic, Rybelsus |
| Amgen INC. | $159.04 | 2023-2025 | Repatha, Otezla, Otezla |
| Neurocrine Biosciences, INC. | $122.76 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.81 | 2021 | |
| Grifols USA, LLC | $54.87 | 2021-2025 | Prolastin-C Liquid |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $53.08 | 2025 | Caplyta |
| Pfizer INC. | $43.58 | 2021 | |
| Glaxosmithkline, LLC. | $43.28 | 2021-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $42.38 | 2023-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $41.62 | 2021-2024 | Epclusa |
| Covis Pharma Gmbh | $40.39 | 2021-2023 | |
| Abbott Laboratories | $37.77 | 2021-2022 | |
| Dexcom, INC. | $35.31 | 2022-2023 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $21.41 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $18.83 | 2025 | Breztri |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.91 | 2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $17.24 | 2022 | |
| Hologic Sales and Service, LLC | $16.09 | 2023 | Aptima, Thinprep 2000 Processor |
| Eisai INC. | $15.82 | 2021 | |
| Lundbeck LLC | $13.60 | 2025 | Rexulti |
| Exeltis, USA INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.